星島(01105.HK):與潛在買家在未來兩個月將獲告知監管機構的批准結果
格隆匯6月5日丨星島(01105.HK)公佈,公司與潛在買家及其各自的法律顧問正合力為潛在交易取得相關監管機構的批准。由於新冠狀病毒病導致業務與政府活動均受阻,需要比原定預期更多的時間以取得監管機構的批准。公司與潛在買家在未來兩個月將獲告知監管機構的批准結果。
潛在買家與其專業顧問繼續對集團進行盡職調查審查,主要包括審查集團的最新業務與公司資料及數據。目前預期該盡職調查審查將繼續,直至獲取監管機構的批准後。
何柱國與潛在買家就潛在交易之磋商仍在進行。何柱國與潛在買家目前擬待獲取監管機構的批准後方訂立任何正式協議。於公告日期,何柱國並未就潛在交易訂立任何正式或具法律約束力之協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.